tiprankstipranks
Tenet Healthcare (DE:THC1)
XETRA:THC1
Germany Market
THC1
Tenet Healthcare
RESEARCH TOOLSreports

Tenet Healthcare (THC1) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

THC1 Analyst Ratings

Strong Buy
15Ratings
Strong Buy
14 Buy
1 Hold
0 Sell
Based on 15 analysts giving stock ratings to
Tenet
Healthcare
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

THC1 Stock 12 Month Forecast

Average Price Target

€239.56
▲(22.22% Upside)
Based on 15 Wall Street analysts offering 12 month price targets for Tenet Healthcare in the last 3 months. The average price target is €239.56 with a high forecast of €267.14 and a low forecast of €212.50. The average price target represents a 22.22% change from the last price of €196.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"138":"€138","203":"€203","268":"€268","170.5":"€170.5","235.5":"€235.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":267.1405814,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€267.14</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":239.55918370999999,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€239.56</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":212.49818975,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€212.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[138,170.5,203,235.5,268],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,220,223.62619856923078,227.25239713846153,230.8785957076923,234.50479427692306,238.13099284615384,241.7571914153846,245.38338998461538,249.00958855384613,252.6357871230769,256.2619856923077,259.8881842615384,263.5143828307692,{"y":267.1405814,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,220,221.5045525930769,223.00910518615385,224.51365777923075,226.0182103723077,227.5227629653846,229.02731555846154,230.53186815153845,232.03642074461538,233.5409733376923,235.04552593076923,236.55007852384614,238.05463111692308,{"y":239.55918370999999,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,220,219.42293767307692,218.84587534615383,218.26881301923078,217.6917506923077,217.1146883653846,216.53762603846153,215.96056371153847,215.38350138461539,214.8064390576923,214.22937673076922,213.65231440384616,213.07525207692308,{"y":212.49818975,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":139,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":156,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":170,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":181,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":185,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":170,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":156,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":200,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":163,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":153,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":147,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":166,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":220,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€267.14Average Price Target€239.56Lowest Price Target€212.50
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on DE:THC1
Stephen Baxter
Wells Fargo
Wells Fargo
€200.36→€243.72
Buy
24.35%
Upside
Assigned
07/31/26
Tenet Healthcare price target raised to $281 from $231 at Wells FargoTenet Healthcare price target raised to $281 from $231 at Wells Fargo
Goldman Sachs Analyst forecast on DE:THC1
Scott Fidel
Goldman Sachs
Goldman Sachs
€218.57→€264.54
Buy
34.97%
Upside
Assigned
07/29/26
Tenet Healthcare price target raised to $305 from $252 at Goldman SachsTenet Healthcare price target raised to $305 from $252 at Goldman Sachs
Truist Financial Analyst forecast on DE:THC1
David S Macdonald
Truist Financial
Truist Financial
€234.18→€251.53
Buy
28.33%
Upside
Reiterated
07/28/26
Truist Financial Remains a Buy on Tenet Healthcare (THC)
Robert W. Baird Analyst forecast on DE:THC1
Michael Ha
Robert W. Baird
Robert W. Baird
€182.14→€242.86
Hold
23.91%
Upside
Reiterated
07/28/26
Tenet Healthcare price target raised to $280 from $210 at BairdTenet Healthcare price target raised to $280 from $210 at Baird
UBS Analyst forecast on DE:THC1
A.J. Rice
UBS
UBS
€249.79→€267.14
Buy
36.30%
Upside
Reiterated
07/27/26
Tenet Healthcare price target raised to $308 from $288 at UBSTenet Healthcare price target raised to $308 from $288 at UBS
Morgan Stanley Analyst forecast on DE:THC1
Craig Hettenbach
Morgan Stanley
Morgan Stanley
€220.3→€237.65
Buy
21.25%
Upside
Reiterated
07/27/26
Tenet Healthcare price target raised to $274 from $254 at Morgan StanleyTenet Healthcare price target raised to $274 from $254 at Morgan Stanley
Guggenheim Analyst forecast on DE:THC1
Jason Cassorla
Guggenheim
Guggenheim
€209.9→€245.46
Buy
25.23%
Upside
Reiterated
07/27/26
Tenet Healthcare price target raised to $283 from $242 at GuggenheimTenet Healthcare price target raised to $283 from $242 at Guggenheim
Stephens Analyst forecast on DE:THC1
Raj Kumar CFA
Stephens
Stephens
€216.83→€247.19
Buy
26.12%
Upside
Reiterated
07/27/26
Tenet Healthcare price target raised to $285 from $250 at StephensTenet Healthcare price target raised to $285 from $250 at Stephens
TD Cowen Analyst forecast on DE:THC1
Ryan Langston
TD Cowen
TD Cowen
€202.09→€228.11
Buy
16.38%
Upside
Assigned
07/27/26
Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (NYSE: THC) and Dexcom (NASDAQ: DXCM)
RBC Capital Analyst forecast on DE:THC1
Ben Hendrix
RBC Capital
RBC Capital
€204.69→€245.46
Buy
25.23%
Upside
Reiterated
07/26/26
Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (NYSE: THC), Legend Biotech (NASDAQ: LEGN) and Vertex Pharmaceuticals (NASDAQ: VRTX)
Bank of America Securities Analyst forecast on DE:THC1
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
€199.49→€229.84
Buy
17.27%
Upside
Reiterated
07/24/26
Analysts' Top Healthcare Picks: Edwards Lifesciences (EW), Atricure (ATRC)
Barclays Analyst forecast on DE:THC1
Andrew Mok CFA
Barclays
Barclays
€208.16→€235.05
Buy
19.92%
Upside
Reiterated
07/24/26
Barclays Sticks to Its Buy Rating for Tenet Healthcare (THC)
Cantor Fitzgerald Analyst forecast on DE:THC1
Sarah James
Cantor Fitzgerald
Cantor Fitzgerald
€212.5
Buy
8.42%
Upside
Reiterated
07/23/26
Tenet Healthcare (THC) Receives a Buy from Cantor Fitzgerald
Mizuho Securities Analyst forecast on DE:THC1
Ann Hynes
Mizuho Securities
Mizuho Securities
€216.83
Buy
10.63%
Upside
Reiterated
07/13/26
Mizuho Securities Reaffirms Their Buy Rating on Tenet Healthcare (THC)
J.P. Morgan Analyst forecast on DE:THC1
Benjamin Rossi
J.P. Morgan
J.P. Morgan
€242.86→€225.51
Buy
15.06%
Upside
Reiterated
05/22/26
J.P. Morgan Sticks to Its Buy Rating for Tenet Healthcare (THC)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on DE:THC1
Stephen Baxter
Wells Fargo
Wells Fargo
€200.36→€243.72
Buy
24.35%
Upside
Assigned
07/31/26
Tenet Healthcare price target raised to $281 from $231 at Wells FargoTenet Healthcare price target raised to $281 from $231 at Wells Fargo
Goldman Sachs Analyst forecast on DE:THC1
Scott Fidel
Goldman Sachs
Goldman Sachs
€218.57→€264.54
Buy
34.97%
Upside
Assigned
07/29/26
Tenet Healthcare price target raised to $305 from $252 at Goldman SachsTenet Healthcare price target raised to $305 from $252 at Goldman Sachs
Truist Financial Analyst forecast on DE:THC1
David S Macdonald
Truist Financial
Truist Financial
€234.18→€251.53
Buy
28.33%
Upside
Reiterated
07/28/26
Truist Financial Remains a Buy on Tenet Healthcare (THC)
Robert W. Baird Analyst forecast on DE:THC1
Michael Ha
Robert W. Baird
Robert W. Baird
€182.14→€242.86
Hold
23.91%
Upside
Reiterated
07/28/26
Tenet Healthcare price target raised to $280 from $210 at BairdTenet Healthcare price target raised to $280 from $210 at Baird
UBS Analyst forecast on DE:THC1
A.J. Rice
UBS
UBS
€249.79→€267.14
Buy
36.30%
Upside
Reiterated
07/27/26
Tenet Healthcare price target raised to $308 from $288 at UBSTenet Healthcare price target raised to $308 from $288 at UBS
Morgan Stanley Analyst forecast on DE:THC1
Craig Hettenbach
Morgan Stanley
Morgan Stanley
€220.3→€237.65
Buy
21.25%
Upside
Reiterated
07/27/26
Tenet Healthcare price target raised to $274 from $254 at Morgan StanleyTenet Healthcare price target raised to $274 from $254 at Morgan Stanley
Guggenheim Analyst forecast on DE:THC1
Jason Cassorla
Guggenheim
Guggenheim
€209.9→€245.46
Buy
25.23%
Upside
Reiterated
07/27/26
Tenet Healthcare price target raised to $283 from $242 at GuggenheimTenet Healthcare price target raised to $283 from $242 at Guggenheim
Stephens Analyst forecast on DE:THC1
Raj Kumar CFA
Stephens
Stephens
€216.83→€247.19
Buy
26.12%
Upside
Reiterated
07/27/26
Tenet Healthcare price target raised to $285 from $250 at StephensTenet Healthcare price target raised to $285 from $250 at Stephens
TD Cowen Analyst forecast on DE:THC1
Ryan Langston
TD Cowen
TD Cowen
€202.09→€228.11
Buy
16.38%
Upside
Assigned
07/27/26
Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (NYSE: THC) and Dexcom (NASDAQ: DXCM)
RBC Capital Analyst forecast on DE:THC1
Ben Hendrix
RBC Capital
RBC Capital
€204.69→€245.46
Buy
25.23%
Upside
Reiterated
07/26/26
Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (NYSE: THC), Legend Biotech (NASDAQ: LEGN) and Vertex Pharmaceuticals (NASDAQ: VRTX)
Bank of America Securities Analyst forecast on DE:THC1
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
€199.49→€229.84
Buy
17.27%
Upside
Reiterated
07/24/26
Analysts' Top Healthcare Picks: Edwards Lifesciences (EW), Atricure (ATRC)
Barclays Analyst forecast on DE:THC1
Andrew Mok CFA
Barclays
Barclays
€208.16→€235.05
Buy
19.92%
Upside
Reiterated
07/24/26
Barclays Sticks to Its Buy Rating for Tenet Healthcare (THC)
Cantor Fitzgerald Analyst forecast on DE:THC1
Sarah James
Cantor Fitzgerald
Cantor Fitzgerald
€212.5
Buy
8.42%
Upside
Reiterated
07/23/26
Tenet Healthcare (THC) Receives a Buy from Cantor Fitzgerald
Mizuho Securities Analyst forecast on DE:THC1
Ann Hynes
Mizuho Securities
Mizuho Securities
€216.83
Buy
10.63%
Upside
Reiterated
07/13/26
Mizuho Securities Reaffirms Their Buy Rating on Tenet Healthcare (THC)
J.P. Morgan Analyst forecast on DE:THC1
Benjamin Rossi
J.P. Morgan
J.P. Morgan
€242.86→€225.51
Buy
15.06%
Upside
Reiterated
05/22/26
J.P. Morgan Sticks to Its Buy Rating for Tenet Healthcare (THC)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
ZURAZura Bio
TNYATenaya Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Tenet Healthcare

3 Months
Andrew Mok CFABarclays
Success Rate
20/26 ratings generated profit
77%
Average Return
+9.76%
Copying Andrew Mok CFA's trades and holding each position for 3 Months would result in 76.92% of your transactions generating a profit, with an average return of +9.76% per trade.
1 Year
David S MacdonaldTruist Financial
Success Rate
26/28 ratings generated profit
93%
Average Return
+35.86%
Copying David S Macdonald's trades and holding each position for 1 Year would result in 92.86% of your transactions generating a profit, with an average return of +35.86% per trade.
2 Years
Jason CassorlaGuggenheim
Success Rate
17/17 ratings generated profit
100%
Average Return
+86.76%
Copying Jason Cassorla's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +86.76% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

THC1 Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
24
16
16
32
23
Hold
0
1
1
2
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
24
17
17
34
24
In the current month, THC1 has received 23 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. THC1 average Analyst price target in the past 3 months is 239.56.
Each month's total comprises the sum of three months' worth of ratings.

THC1 Financial Forecast

THC1 Earnings Forecast

Next quarter’s earnings estimate for THC1 is €3.98 with a range of €2.96 to €4.38. The previous quarter’s EPS was €5.32. THC1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.99% of the time in the same period. In the last calendar year THC1 has Performed in-line its overall industry.
Next quarter’s earnings estimate for THC1 is €3.98 with a range of €2.96 to €4.38. The previous quarter’s EPS was €5.32. THC1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.99% of the time in the same period. In the last calendar year THC1 has Performed in-line its overall industry.

THC1 Sales Forecast

Next quarter’s sales forecast for THC1 is €4.76B with a range of €4.63B to €4.83B. The previous quarter’s sales results were €4.89B. THC1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.69% of the time in the same period. In the last calendar year THC1 has Performed in-line its overall industry.
Next quarter’s sales forecast for THC1 is €4.76B with a range of €4.63B to €4.83B. The previous quarter’s sales results were €4.89B. THC1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.69% of the time in the same period. In the last calendar year THC1 has Performed in-line its overall industry.

THC1 Stock Forecast FAQ

What is DE:THC1’s average 12-month price target, according to analysts?
Based on analyst ratings, Tenet Healthcare’s 12-month average price target is 239.56.
    What is DE:THC1’s upside potential, based on the analysts’ average price target?
    Tenet Healthcare has 22.22% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Tenet Healthcare a Buy, Sell or Hold?
          Tenet Healthcare has a consensus rating of Strong Buy, which is based on 14 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Tenet Healthcare’s share price target?
            The average share price target for Tenet Healthcare is 239.56. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €267.14 ,and the lowest forecast is €212.50. The average share price target represents 22.22% Increase from the current price of €196.
              What do analysts say about Tenet Healthcare?
              Tenet Healthcare’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.
                How can I buy shares of Tenet Healthcare?
                To buy shares of DE:THC1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.